immune system
• mice intraperitoneally injected with one dose of LPS exhibit a survival advantage against endotoxin lethality, with over 30% of mice remaining alive at 72 hours compared to 100% lethality of wild-type mice within 54 hours after LPS injection
• LPS-treated mice exhibit higher body temperatures, lower composite clinical scores, and lower expression of proinflammatory cytokines TNF-alpha and proIL-1beta in peritoneal CD45+F4/80+CD11b+ macrophages and lower serum levels of these cytokines at 3 and 6 hours of LPS administration
• LPS-primed bone marrow-derived macrophages exhibit lower concentrations of profinflammatory proIL-1beta, IL-6, and TNF-alpha cytokines and show attenuation of the oxygen consumption rate (OCR, as measured by maximal respiration), ATP-leaked respiration, and the separate respiration capacity
• mice show attenuated secretion of proinflammatory mitochondrial reactive oxygen species (mtROS) following LPS treatment
• however, mice exhibit normal macrophage development and normal T cell development in the thymus and spleen
|